NZYM B Novozymes A/S Class B

Change to the Executive Leadership Team

Change to the Executive Leadership Team

Jacob Vishof Paulsen will be leaving his position as Executive Vice President of Food & Beverage Biosolutions, as he has accepted a role outside of Novonesis, effective March 31, 2025.

Ester Baiget, President & CEO comments: “I want to thank Jacob for his strong leadership and commitment to Novonesis and our Food & Beverage Biosolutions business. Jacob has played an instrumental role in Novonesis. As a result of his contribution, the Food & Beverage Biosolutions business in Novonesis rests on a solid foundation with an extraordinary team and is uniquely positioned to drive continued growth and deliver innovative solutions to our customers. I wish Jacob all the best on his future journey.”

Jacob joined Chr. Hansen in 2006 and became a member of the Corporate Leadership Team in 2013. During his tenure in Chr. Hansen, Jacob has held multiple global sales and business unit leadership positions and since 2019 been responsible for the Food Cultures & Enzymes business unit, before entering his current role in Novonesis.

Jacob Vishof Paulsen, EVP of Food & Beverage Biosolutions continues: “I am proud of having been part of Novonesis and see amazing potential in this company. I am thankful for my time with the company and the tremendous opportunities it has provided. What I will remember the most is the people that I have worked with across the global organization.”

The search for a replacement has been initiated and an announcement will follow in due time.



Contact information

Investor Relations               

Tobias Bjorklund                                               

Anders Enevoldsen                                           

Katrine Spedtsberg Poulsen                                                     

Media Relations                  

Benjamin Hjorth                                                

Attachment



EN
21/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Novozymes A/S Class B

 PRESS RELEASE

Major shareholder announcement

Major shareholder announcement Please read the full announcement in PDF. Attachments

 PRESS RELEASE

Biosolutions could create more than 600,000 jobs and unlock hundreds o...

Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe A new report reveals that biosolutions could generate EUR 133 billion in economic gains and create over 600,000 jobs across all of Europe by 2035. But without urgent policy leadership and better regulation, Europe risks becoming the world’s best lab for solutions that scale elsewhere. Copenhagen, Denmark – 7 July 2025: Europe is on the verge of a job and growth boom if bio...

 PRESS RELEASE

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated  1,729,099 shares with a transaction value of DKK 745,2 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025. Please read the full announcement in PDF. Attachment

 PRESS RELEASE

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program As of June 20th, 2025, Novonesis has purchased an accumulated 1,660,344 shares with a transaction value of DKK 713,0 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025. Under the program, Novonesis will buy back B shares worth up to EUR 100 million (DKK 746 million) in total during the remainder of 2025. Please read the full announcement in PDF  Attachment

 PRESS RELEASE

Major shareholder announcement

Major shareholder announcement Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments. Per June 19, 2025, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,343,678 shares, corresponding to 4.98% (previously 5.02%) of the total share capital attached to shares. The combined total of share capital attached to shares and share capital through financial instruments i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch